Cargando…

A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer

BACKGROUND: The addition of bevacizumab to standard chemotherapy prolongs progression free survival in the first line treatment of epithelial ovarian cancer (EOC), but its cost/effectiveness is debated. We assessed the safety and activity of a lower dose of bevacizumab in pretreated advanced stage E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Defferrari, Carlotta, Campora, Sara, D'Amico, Mauro, Piccardo, Arnoldo, Biscaldi, Ennio, Rosselli, Daniela, Pasa, Ambra, Puntoni, Matteo, Gozza, Alberto, Gennari, Alessandra, Zanardi, Silvia, Lionetto, Rita, Bandelloni, Michela, DeCensi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408333/ https://www.ncbi.nlm.nih.gov/pubmed/22732001 http://dx.doi.org/10.1186/1757-2215-5-17

Ejemplares similares

Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer
por: Campora, Sara, et al.
Publicado: (2016)

Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic
por: Buttiron Webber, Tania, et al.
Publicado: (2021)

Late-Onset Metastasis of Renal Cell Carcinoma into a Hot Thyroid Nodule: An Uncommon Finding Not to Be Overlooked
por: Foppiani, Luca, et al.
Publicado: (2015)

Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment
por: Buttiron Webber, Tania, et al.
Publicado: (2021)

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
por: Martin, Jovana Y., et al.
Publicado: (2016)

Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
por: Liu, Xiu, et al.
Publicado: (2023)

Value of Fused (18)F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results
por: Piccardo, Arnoldo, et al.
Publicado: (2014)

Corrigendum to “Value of Fused (18)F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results”
por: Piccardo, Arnoldo, et al.
Publicado: (2016)

To Enhance or Not to Enhance? The Role of Contrast Medium (18)F-FDG PET/CT in Recurrent Ovarian Carcinomas
por: Massollo, Michela, et al.
Publicado: (2021)

Analysis of the activity and safety of weekly low‐dose bevacizumab‐based regimens in heavily pretreated patients with metastatic breast cancer
por: Zhai, Xiaoyu, et al.
Publicado: (2018)

A Three-Domain Scoring System to Customize the Risk of Relapse of Differentiated Thyroid Carcinoma
por: Piccardo, Arnoldo, et al.
Publicado: (2021)

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial
por: DeCensi, Andrea, et al.
Publicado: (2021)

Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature
por: Agostino, Nicole M., et al.
Publicado: (2010)

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
por: Yang, Qiong, et al.
Publicado: (2015)

Contemporary Approach to Heavily Calcified Coronary Lesions
por: Sorini Dini, Carlotta, et al.
Publicado: (2019)

Biokinetic and dosimetric aspects of (64)CuCl(2) in human prostate cancer: possible theranostic implications
por: Righi, Sergio, et al.
Publicado: (2018)

Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial
por: Li, Ting, et al.
Publicado: (2015)

Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment
por: Cuttica, Carla Micaela, et al.
Publicado: (2023)

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
por: Richardson, Paul G., et al.
Publicado: (2021)

Heavily doped semiconductors
por: Fistul’, Victor I
Publicado: (1995)

Percutaneous trans-hepatic rescue and neo-creation of a post-surgical complete hepaticojejunostomy dehiscence
por: Rossi, Umberto Geremia, et al.
Publicado: (2021)

The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
por: Oriol, Albert, et al.
Publicado: (2021)

Long-lasting effect of belantamab mafodotin in heavily pretreated multiple myeloma
por: Gil-Sierra, Manuel David, et al.
Publicado: (2022)

The effect of metformin on apoptosis in a breast cancer presurgical trial
por: Cazzaniga, M, et al.
Publicado: (2013)

A Presurgical Study of Curcumin Combined with Anthocyanin Supplements in Patients with Colorectal Adenomatous Polyps
por: Briata, Irene Maria, et al.
Publicado: (2021)

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study
por: Oza, Amit M., et al.
Publicado: (2017)

Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysis
por: Hu, Ran, et al.
Publicado: (2021)

Topotecan Monotherapy in Heavily Pretreated Patients with Progressive Advanced Stage Neuroendocrine Carcinomas
por: Olsen, Ingrid Holst, et al.
Publicado: (2014)

A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide
por: Cerchione, Claudio, et al.
Publicado: (2017)

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2021)

Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
por: Delforge, Michel, et al.
Publicado: (2022)

Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent
por: Capriotti, Gabriela, et al.
Publicado: (2022)

The relevance of complete imaging investigations in lymphomatoid papulosis
por: Chersi, Filippo, et al.
Publicado: (2022)

Diagnostic tests for medullary thyroid carcinoma: an umbrella review
por: Trimboli, Pierpaolo, et al.
Publicado: (2023)

Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake
por: DeCensi, Andrea, et al.
Publicado: (2015)

Taste and Smell Disorders in Cancer Treatment: Results from an Integrative Rapid Systematic Review
por: Buttiron Webber, Tania, et al.
Publicado: (2023)

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia
por: DeCensi, Andrea, et al.
Publicado: (2019)

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
por: Yamaguchi, Kazuhisa, et al.
Publicado: (2015)

Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
por: Cohen, Samantha, et al.
Publicado: (2019)

ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study
por: Monti, Manuela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tp9ke1169n59de2bmnstuc54bv